- UK rolls out AstraZeneca-Oxford vaccine
- Georgia Senate runoff elections
- US stocks sink, European indices finished session slightly higher
The European stock market started the first session of the year higher, however momentum faded away in the afternoon as investors were concerned about the impact of new restrictive measures on the EU economy. Germany extended lockdown until January 31st; while Scotland introduced a national lockdown similar to the one introduced in March. British Prime Minister Boris Johnson warned that he may have to impose tighter restrictions as Covid-19 cases soar. Early in the session sentiment was lifted on news, that Britain became the first country to roll out the Covid-19 vaccine developed by AstraZeneca (AZN.UK) and Oxford University, a cheaper and more easily stored alternative to the vaccine developed by Pfizer (PFE.US) and BioNTech(BNTX.US), which is already in use. Meanwhile PMI surveys showed the Eurozone manufacturing sector grew in December by the most since May 2018. DAX 30 finished today's session near the flat line at 13,727, CAC rose 0.7 % and FTSE100 gained 1.8%.
The Dow Jones and the S&P 500 launched today's session at fresh record highs but soon bears managed to take control and all three major indices are trading more than 2% lower with shares of Coca-Cola and Boeing among the worst performers. Tesla stock jumped 4% after the company reported better-than-expected December deliveries numbers. Politics weighed on market sentiment as the prospect of the runoff elections for Georgia's two Senate seats could tip control of the upper chamber to the Democrats and usher in a more radical fiscal policy agenda from the new administration. President Donald Trump put pressure on Georgia's Secretary of State Brad Raffensberger to overturn President-elect Joe Biden’s victory in the state by finding votes to shift the count in his favor, according to audio obtained by NBC News. Meanwhile global Covid-19 cases surpassed 85 million, of which more than 20.6 million in the US and the surge could intensify as Colorado, California and Florida identified cases of the highly transmissible Covid-19 variant that emerged in the UK. US has administered more than 4.2 million vaccine doses so far and the pace is picking up, according to Dr. Fauci. On the data front, US Manufacturing PMI was revised higher to 57.1 pts in December from a preliminary of 56.5 and 56.7 in November. The reading pointed to the strongest growth in factory activity since September of 2014.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appUS crude futures are trading 1.8% lower at $ 47.63 a barrel, while Brent contract fell 1.3% to $ 51.09 as investors await the OPEC+ meeting outcome. Elsewhere, gold futures rose 2.0% to $ 1,937.50 /oz, while silver is trading 2.50% higher near $ 27.04/oz. Bitcoin fell sharply today, after reaching record high of $34,800 on Sunday, with traders citing volatility in highly leveraged futures markets.
Silver price is testing major resistance at $27.50/oz. If sellers will manage to break higher, then another upward impulse towards next resistance at $29.00/oz could be launched. Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
